All transactions
December 2021
Advisor to DCC on the sale to Foxway
ATRIUM Partners acted as exclusive financial advisor to circular IT reseller DCC on the sale to Foxway. DCC is one […]
August 2021
Advisor to Retune DSP on the sale to NXP Semiconductors
ATRIUM Partners acted as exclusive financial advisor to audio software company Retune DSP in the sale to NXP Semiconductors. Retune […]
August 2021
Advisor to Swire Energy Services on the acquisition of ALL NRG
ATRIUM Partners acted as exclusive financial advisor to Swire Energy Services (SES) on its acquisition of ALL NRG from VIA […]
May 2021
Advisor to HydroPen on the sale to Viking Life-Saving Equipment
VIKING Life-Saving Equipment. HydroPen is a specialized marine engineering company that develops and manufactures solutions for fighting container fires. HydroPen […]
January 2021
Financial advisor on the merger between Den Jyske Sparekasse and Vestjysk Bank
ATRIUM Partners acted as exclusive financial advisor to Den Jyske Sparekasse A/S in connection with the proposed merger with Vestjysk […]
January 2021
Advisor to Consolidated Holdings on the sale of Netop to Impero Software
ATRIUM acted as exclusive financial advisor to the owners of Netop Solutions in connection with the divestment to Impero Software, […]
December 2020
Advisor to Columbus on the divestment of To‑Increase to Gilde Buy Out Partners
ATRIUM acted as exclusive financial advisor to Columbus in connection with the divestment of To-Increase to Gilde Buy Out Partners […]
August 2020
Advisor to TF-Technologies on the sale to Fayat Group
ATRIUM was exclusive financial advisor to the shareholders of TF-Technologies in connection with the sale to Fayat Group. TF-Technologies develops […]
April 2020
Advisor to DSM in its 765 million EUR acquisition of Glycom
ATRIUM acted as exclusive financial advisor to Royal DSM in the acquisition of Glycom A/S. Glycom is the world’s leading […]
July 2019
Advisor to IWA Consulting on the sale to VCLS
ATRIUM acted as exclusive financial advisor to the owners of IWA Consulting on the sale to Voisin Consulting Life Sciences (VCLS). […]
